Matthew D. Wilkerson

103.4k citations

72 papers · 5.7k indexed · 1 hit paper · h-index 21

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 11
- Cancer-related molecular mechanisms research 6
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations 8
Molecular Biology top 2%
- Genomics and Phylogenetic Studies 10
- RNA modifications and cancer 8
- Molecular Biology Techniques and Applications 5
- Gene expression and cancer classification 5
- Epigenetics and DNA Methylation 5
Oncology top 2%
Immunology top 5%

Co-authors: D. Neil Hayes Charles M. Perou Ke Xian A. C. S. Peacock Volker Brendel Joel S. Parker Christopher R. Cabanski Katherine A. Hoadley
Cited by: Cancer Research Pulmonary and Respiratory Medicine Molecular Biology
Journals: Nucleic Acids Research (4 papers)Nature Communications (1 paper)Journal of Clinical Oncology (4 papers)
Partner nations: United States Germany Poland

In The Last Decade

Matthew D. Wilkerson

69 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Matthew D. Wilkerson

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Wilkerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Wilkerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Wilkerson more than expected).

Fields of papers citing papers by Matthew D. Wilkerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Wilkerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Wilkerson. The network helps show where Matthew D. Wilkerson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew D. Wilkerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew D. Wilkerson Line = papers co-authored together Matthew D. Wilkerson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Wild-type RAS signaling is an essential therapeutic target in RAS -mutated cancers Science Signaling ·Nancy E. Sealover,Bridget A. Finniff,Jacob M. Hughes,Erin Sheffels,Hyun Lee,Joseph P. LaMorte,Vainavi Gambhir,Zaria Beckley,Amanda J. Linke,Matthew D. Wilkerson,Marielle E. Yohe,Robert L. Kortum	2025	0
2	The influence of microbial colonization on inflammatory versus pro-healing trajectories in combat extremity wounds Scientific Reports ·Seth Schobel,Eric R. Gann,Desiree Unselt,Scott F. Grey,Felipe Lisboa,Meenu M. Upadhyay,Michael Rouse,Simon Tallowin,Nicholas A. Be,Xijun Zhang,Clifton L. Dalgard,Matthew D. Wilkerson,Miloš Hauskrecht,Stephen F. Badylak,Rubén Zamora,Yoram Vodovotz,Benjamin K. Potter,Thomas A. Davis,Eric A. Elster	2024	3
3	Uncommon Protein-Coding Variants Associated With Suicide Attempt in a Diverse Sample of U.S. Army Soldiers Biological Psychiatry ·Matthew D. Wilkerson,Daniel Hupalo,Joshua C. Gray,Xijun Zhang,Jiawei Wang,Matthew J. Girgenti,Camille Alba,Gauthaman Sukumar,Nathaniel M. Lott,James A. Naifeh,Pablo A. Aliaga,Ronald C. Kessler,Clesson Turner,Harvey B. Pollard,Clifton L. Dalgard,Robert J. Ursano,Murray B. Stein	2023	2
4	Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment Gynecologic Oncology ·Wei Ao,Hong Im Kim,Domenic Tommarello,Kelly A. Conrads,Brian L. Hood,Tracy Litzi,Tamara Abulez,Pang-ning Teng,Clifton L. Dalgard,Xijun Zhang,Matthew D. Wilkerson,Kathleen M. Darcy,Christopher M. Tarney,Neil T. Phippen,Christopher J. Bakkenist,G. Larry Maxwell,Thomas P. Conrads,John I. Risinger,Nicholas W. Bateman	2023	1
5	Transcriptomic Profiling and Pathway Analysis of Mesenchymal Stem Cells Following Low Dose-Rate Radiation Exposure Antioxidants ·John E. Slaven,Matthew D. Wilkerson,Anthony R. Soltis,W. Bradley Rittase,Dmitry T. Bradfield,Michelle A. Bylicky,Lynnette Cary,Alena Tsioplaya,Roxane M. Bouten,Clifton L. Dalgard,Regina M. Day	2023	4
6	Tensin 1 ( TNS1 ) is a modifier gene for low body mass index (BMI) in homozygous [ F508del ]CFTR patients Physiological Reports ·Nathan I. Walton,Xijun Zhang,Anthony R. Soltis,Joshua Starr,Clifton L. Dalgard,Matthew D. Wilkerson,Douglas Conrad,Harvey B. Pollard	2021	2
7	Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Jeremiah Holt,Vonn Walter,Xiaoying Yin,David Marron,Matthew D. Wilkerson,Hyo Young Choi,Xiaobei Zhao,Heejoon Jo,D. Neil Hayes,Yoon Ho Ko	2020	9
8	Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients Respiratory Research ·Qingfeng Yang,Anthony R. Soltis,Gauthaman Sukumar,X. Zhang,H. Caohuy,J. Freedy,Clifton L. Dalgard,Matthew D. Wilkerson,Harvey B. Pollard,B. Pollard	2019	10
9	Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis Journal of Investigative Dermatology ·Kathleen Conway,Sharon N. Edmiston,Joel S. Parker,Pei Fen Kuan,Yi‐Hsuan Tsai,Pamela A. Groben,Daniel C. Zedek,Glynis Scott,Eloise Parrish,Honglin Hao,Michelle V. Pearlstein,Jill S. Frank,Craig C. Carson,Matthew D. Wilkerson,Xiaobei Zhao,Nathaniel A. Slater,Stergios J. Moschos,David W. Ollila,Nancy E. Thomas	2018	25
10	Chromaffin cell biology: inferences from The Cancer Genome Atlas Cell and Tissue Research ·Lauren Fishbein,Matthew D. Wilkerson	2018	18
11	IGF-1 Receptor Insufficiency Leads to Age-Dependent Attenuation of Osteoblast Differentiation Endocrinology ·Lee‐Chuan C. Yeh,Matthew D. Wilkerson,John C. Lee,Martin L. Adamo	2015	6
12	BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization Cancer Research ·Tess Orvis,Austin J. Hepperla,Vonn Walter,Shujie Song,Jeremy M. Simon,Joel S. Parker,Matthew D. Wilkerson,Nisarg Desai,Michael B. Major,D. Neil Hayes,Ian J. Davis,Bernard E. Weissman	2014	102
13	SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples Nucleic Acids Research ·Patrick K. Kimes,Christopher R. Cabanski,Matthew D. Wilkerson,Ni Zhao,Amy Johnson,Charles M. Perou,Liza Makowski,Christopher A. Maher,Yufeng Liu,J. S. Marron,D. Neil Hayes	2014	14
14	Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Cancer Research ·Rachel G. Liao,Joonil Jung,Jeremy H. Tchaicha,Matthew D. Wilkerson,Andrey Sivachenko,Ellen M. Beauchamp,Qingsong Liu,Trevor J. Pugh,Chandra Sekhar Pedamallu,D. Neil Hayes,Nathanael S. Gray,Gad Getz,Kwok‐Kin Wong,Robert I. Haddad,Matthew Meyerson,Peter S. Hammerman	2013	134
15	Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens Journal of Molecular Diagnostics ·Matthew D. Wilkerson,Jason Schallheim,D. Neil Hayes,Patrick J. Roberts,Roy R. L. Bastien,Michael E. Mullins,Xiaoying Yin,C. Ryan Miller,Leigh B. Thorne,Katherine B. Geiersbach,Kenneth L. Muldrew,William K. Funkhouser,Cheng Fan,Michele C. Hayward,Steven R Bayer,Charles M. Perou,Philip S. Bernard	2013	16
16	ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data BMC Bioinformatics ·Christopher R. Cabanski,Keary Cavin,Chris Bizon,Matthew D. Wilkerson,Joel S. Parker,Kirk C. Wilhelmsen,Charles M. Perou,J. S. Marron,D. Neil Hayes	2012	13
17	Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation PLoS ONE ·Matthew D. Wilkerson,Xiaoying Yin,Vonn Walter,Ni Zhao,Christopher R. Cabanski,Michele C. Hayward,C. Ryan Miller,Mark A. Socinski,Alden M. Parsons,Leigh B. Thorne,Benjamin E. Haithcock,Nirmal K. Veeramachaneni,William K. Funkhouser,Scott H. Randell,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	2012	192
18	Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types Clinical Cancer Research ·Matthew D. Wilkerson,Xiaoying Yin,Katherine A. Hoadley,Yufeng Liu,Michele C. Hayward,Christopher R. Cabanski,Kenneth L. Muldrew,C. Ryan Miller,Scott H. Randell,Mark A. Socinski,Alden M. Parsons,William K. Funkhouser,Carrie B. Lee,Patrick J. Roberts,Leigh B. Thorne,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	2010	194
19	yrGATE: a web-based gene-structure annotation tool for the identification and dissemination of eukaryotic genes Genome biology ·Matthew D. Wilkerson,Shannon D. Schlueter,Volker Brendel	2006	17
20	Community-based gene structure annotation Trends in Plant Science ·Shannon D. Schlueter,Matthew D. Wilkerson,Eva Huala,Seung Y. Rhee,Volker Brendel	2004	18

About Matthew D. Wilkerson

Matthew D. Wilkerson is a scholar working on Cancer Research, Behavioral Neuroscience and Molecular Biology, having authored 72 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Genomics and Phylogenetic Studies (10 papers), RNA modifications and cancer (8 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer-related molecular mechanisms research (6 papers), Molecular Biology Techniques and Applications (5 papers), Gene expression and cancer classification (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (2.1k citations) and Molecular Biology (3.3k citations). Matthew D. Wilkerson has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include D. Neil Hayes, Charles M. Perou, Ke Xian, A. C. S. Peacock, Volker Brendel, Joel S. Parker, Christopher R. Cabanski, Katherine A. Hoadley, Carolyn J. Lawrence and Xiaoying Yin. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact